Is Mammography for Breast Cancer Screening Cost-Effective in Both Western and Asian Countries?: Results of a Systematic Review
Uloženo v:
| Název: | Is Mammography for Breast Cancer Screening Cost-Effective in Both Western and Asian Countries?: Results of a Systematic Review |
|---|---|
| Autoři: | Jeoung A. Kwon, Eun Kyung Kim, Moon Hae Kang, Kui Son Choi, Yun Jeong Choi, Eun Cho, Jung Mo Nam, Ki Bong Yoo, Eun Cheol Park |
| Přispěvatelé: | Ki-Bong Yoo, Jeoung A Kwon, Eun Cho, Moon Hae Kang, Jung-Mo Nam, Kui Son Choi, Eun Kyung Kim, Yun Jeong Choi, Eun-Cheol Park, Kim, Eun Kyung, Nam, Jung Mo, Park, Eun Chul, Kim, Eun-Kyung |
| Zdroj: | Asian Pacific Journal of Cancer Prevention. 14:4141-4149 |
| Informace o vydavateli: | Asian Pacific Organization for Cancer Prevention, 2013. |
| Rok vydání: | 2013 |
| Témata: | mass screening, Asia, Mammography/economics, mammography, Cost-Benefit Analysis, Early Detection of Cancer/economics, Breast Neoplasms, 03 medical and health sciences, breast cancer, 0302 clinical medicine, Breast Neoplasms/economics, Humans, Breast Neoplasms/prevention & control, Early Detection of Cancer, Breast Neoplasms/diagnosis, Prognosis, United Kingdom, United States, 3. Good health, Europe, Female, Cost-Effectiveness, Systematic Review, Mammography |
| Popis: | Mammography is considered the gold standard of breast cancer mass screening and many countries have implemented this as an established breast cancer screening strategy. However, although the incidence of breast cancer and racial characteristics are different between Western and Asian countries, many Asian countries adopted mammography for mass screening. Therefore, the objective of this research was to determine whether mammography mass screening is cost-effective for both Western and Asian countries.A systematic review was performed of 17 national mammography cost-effectiveness data sets. Per capita gross domestic product (GDP), breast cancer incidence rate, and the most optimal cost- effectiveness results [cost per life year saved (LYS)] of a mammography screening strategy for each data set were extracted. The CE/per capita GDP ratio is used to compare the cost-effectiveness of mammography by countries. Non-parametric regression was used to find a cut-off point which indicated the breast cancer incidence rate boundary line determining whether mammography screening is cost-effective or not.We found that the cost-effective cut-off point of breast cancer incidence rate was 45.04; it exactly divided countries into Western and Asian countries (p |
| Druh dokumentu: | Article |
| Jazyk: | English |
| ISSN: | 1513-7368 |
| DOI: | 10.7314/apjcp.2013.14.7.4141 |
| Přístupová URL adresa: | http://society.kisti.re.kr/sv/SV_svpsbs03V.do?method=download&cn1=JAKO201332479511896 https://pubmed.ncbi.nlm.nih.gov/23991967 https://mdanderson.elsevierpure.com/en/publications/is-mammography-for-breast-cancer-screening-cost-effective-in-both https://pubmed.ncbi.nlm.nih.gov/23991967/ http://www.ncbi.nlm.nih.gov/pubmed/23991967 http://www.koreascience.or.kr:80/article/JAKO201332479511896.pdf http://koreascience.or.kr/article/JAKO201332479511896.page https://yonsei.pure.elsevier.com/en/publications/is-mammography-for-breast-cancer-screening-cost-effective-in-both |
| Rights: | CC BY CC BY NC ND |
| Přístupové číslo: | edsair.doi.dedup.....8712c521dcc5b2b8c82ca00f3d77ddf6 |
| Databáze: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstrakt: | Mammography is considered the gold standard of breast cancer mass screening and many countries have implemented this as an established breast cancer screening strategy. However, although the incidence of breast cancer and racial characteristics are different between Western and Asian countries, many Asian countries adopted mammography for mass screening. Therefore, the objective of this research was to determine whether mammography mass screening is cost-effective for both Western and Asian countries.A systematic review was performed of 17 national mammography cost-effectiveness data sets. Per capita gross domestic product (GDP), breast cancer incidence rate, and the most optimal cost- effectiveness results [cost per life year saved (LYS)] of a mammography screening strategy for each data set were extracted. The CE/per capita GDP ratio is used to compare the cost-effectiveness of mammography by countries. Non-parametric regression was used to find a cut-off point which indicated the breast cancer incidence rate boundary line determining whether mammography screening is cost-effective or not.We found that the cost-effective cut-off point of breast cancer incidence rate was 45.04; it exactly divided countries into Western and Asian countries (p |
|---|---|
| ISSN: | 15137368 |
| DOI: | 10.7314/apjcp.2013.14.7.4141 |